H19 and hepatocellular carcinoma: Moreover, adding complexity to the regulatory landscape, miR-483-5p itself can act upstream in HCC by binding the IGF2/H19 enhancer, forming chromatin loops via MED1, and thereby transcriptionally upregulating both its host gene IGF2 and the neighboring oncogenic lncRNA H19, promoting malignancy [75].